Rare diseases
Investigational molecules
Locations
Back to Poland19 clinical trials in Trzebnica, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen
PolandSafety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease
PolandA study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma
PolandStudy of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months
PolandSafety, Tolerability and Immunogenicity of RSV prefusion F protein 847a and 847b Vaccine in Children 5‑17 Years at High Risk of RSV Disease
PolandSafety and immune response of PF-07872412 compared with 20-valent pneumococcal conjugate vaccine for pneumococcal disease in healthy children and adolescents
PolandLong‑Term Safety and Tolerability Study of Oral KT‑621 in Adults with Uncontrolled Moderate‑to‑Severe Eosinophilic Asthma
PolandStudy on the Safety and Tolerability of Sisunatovir in Infants and Children with RSV Infection
PolandStudy on the Effectiveness and Safety of the VLA15 Vaccine for Preventing Lyme Disease in Healthy Individuals Aged 5 and Older
PolandStudy of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
PolandStudy on the Safety of a New Chickenpox Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months
PolandStudy on the Safety and Immune Response of mRNA-1345 and mRNA-1365 for Infants with Acute Lower Respiratory Infection Aged 5 to 24 Months
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on meningococcal vaccines for infants and toddlers, evaluating both immunogenicity and safety profiles of new conjugate formulations.
These trials aim to enhance protection against multiple meningococcal serogroups in young children.
Comprehensive studies addressing respiratory syncytial virus (RSV) and respiratory infections in pediatric populations.
Current research focuses on developing effective treatments and preventive measures for respiratory conditions.
Advanced research into eosinophilic asthma and seasonal allergic conditions, with particular attention to long-term treatment effectiveness.
Trials are evaluating innovative treatments for better respiratory disease management in various age groups.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
